Patent · US Active

Command and control cyber vaccine

US10104120B2 · kind B2 · utility

6Cited by
3References
20Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 23, 2017
Grant dateOct 16, 2018
Priority date
Expiry dateMar 23, 2037

Classification

  • Technology area (CPC H)Electricity
  • CPC primaryH04L63/145
  • WIPO fieldDigital communication
  • WIPO sectorElectrical engineering

Abstract

Provided are systems, methods, and computer program products for a cyber-antibody technique. In various implementations, the technique includes monitoring, by a network device infected with an unknown malware program, packets set by the network device onto a network. The technique further includes identifying a packet that is associated with the unknown malware program. The packet can be identified from among the monitored packets. Identifying the packet can include determining a characteristic of the packet. The technique further includes identifying packets that have a characteristic similar to the characteristic of the packet. The technique can further include inserting data associated with a known malware program into the identified packets. The technique can further include distributing the characteristic to other network devices, to similarly taint packets that may be issued from those other network devices.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.